SC
NVO

Savant Capital’s Novo Nordisk NVO Stock Holding History

Savant Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.58M Buy
59,020
+47,972
+434% +$2.06M 0.01% 549
2026
Q1 		$406K Sell
11,048
-1,167
-10% -$55.3K ﹤0.01% 1018
2025
Q4 		$622K Buy
12,215
+624
+5% +$31.9K ﹤0.01% 747
2025
Q3 		$643K Sell
11,591
-355
-3% -$20.8K ﹤0.01% 708
2025
Q2 		$825K Buy
11,946
+130
+1% +$8.84K 0.01% 585
2025
Q1 		$821K Sell
11,816
-2,143
-15% -$177K 0.01% 536
2024
Q4 		$1.2M Buy
13,959
+1,640
+13% +$177K 0.01% 585
2024
Q3 		$1.47M Sell
12,319
-268
-2% -$35.7K 0.01% 519
2024
Q2 		$1.8M Buy
12,587
+1,751
+16% +$232K 0.02% 411
2024
Q1 		$1.39M Buy
10,836
+507
+5% +$60.4K 0.02% 451
2023
Q4 		$1.07M Sell
10,329
-251
-2% -$24.8K 0.01% 401
2023
Q3 		$962K Buy
10,580
+506
+5% +$44.6K 0.01% 393
2023
Q2 		$815K Buy
10,074
+294
+3% +$24K 0.01% 420
2023
Q1 		$778K Buy
9,780
+550
+6% +$39K 0.01% 377
2022
Q4 		$571K Buy
9,230
+2,142
+30% +$126K 0.01% 342
2022
Q3 		$353K Sell
7,088
-422
-6% -$22.6K 0.01% 399
2022
Q2 		$418K Sell
7,510
-244
-3% -$13.5K 0.01% 372
2022
Q1 		$431K Sell
7,754
-486
-6% -$24.9K 0.01% 383
2021
Q4 		$461K Buy
+8,240
New +$446K 0.01% 370

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Savant Capital's NVO Position: Q2 2026 in Review

Savant Capital increased its Novo Nordisk (NVO) stake by 434% in Q2 2026, buying an estimated $2.06M and bringing the position to 59,020 shares worth $2.58M. The position accounts for 0.01% of the portfolio, ranked #549.

Savant Capital first reported a position in NVO in Q4 2021 and has held it in 19 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Savant Capital held 59,020 shares of Novo Nordisk worth $2.58M as of Q2 2026.
  • Savant Capital bought 47,972 Novo Nordisk shares in Q2 2026, an estimated $2.06M.
  • Novo Nordisk made up 0.01% of Savant Capital's portfolio in Q2 2026, its #549 holding.
  • Savant Capital first reported a position in Novo Nordisk in Q4 2021 and has held it in 19 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.